ResearchClinical trial on standardised celandine extract in patients with functional epigastric complaints: results of a placebo-controlled double-blind trial
References (11)
- et al.
Biogene Gifte
- et al.
Klinischexperimentelle Untersuchungen der Gallen, Pankreas und Magensaftskretion under den phytocholagogen Wirkstoffen einer Carduus marianus-Chelidonium-Curcuma-Suspension
Arzneimittelforschung
(1971) - et al.
Prüfung der choleretischen Aktivität eines pflanzlichen Cholagogums
Z Allg Med
(1991) Gallenbeschwerden: Rasche Hilf mit konservativer Therapie, Ergebnisse einer multizentrischen Feldstudie mit Chelidonin
Arztliche Praxis
(1980)
Cited by (18)
Chelidonium majus crude extract inhibits migration and induces cell cycle arrest and apoptosis in tumor cell lines
2016, Journal of EthnopharmacologyCitation Excerpt :Description and medicinal uses of this plant are monographed in the European Pharmacopoeia and in a national pharmacopoeia, and reported in well established documents (EMA/HMPC, 2011). A number of pharmacological properties, e.g. spasmolitic (Hiller et al., 1998), anti-inflammatory (Lee et al., 2007), antioxidant (Jakovljević et al., 2013), antiulcer (Khayyal et al., 2001), antibacterial (Zuo et al., 2008), antiviral (Gerencer et al., 2006), immunomodulatory (Chung et al., 2004; Song et al., 2002) and antitumor (Aljuraisy et al., 2012; Mahmoud et al., 2013) have been reviewed and supported by clinical data (Knöpfel, 1991; Ritter et al., 1993). By virtue of these properties C. majus is widely used in alternative medicine to treat liver diseases, gastric ulcer and spasm, oral infections, rheumatic diseases, tuberculosis and jaundice (Abu, 1956; Amirdowlat, 1990; Mills and Bone, 2000; Pelagić, 1893; Zadorozhnyj, 1990).
Alkaloids from Chelidonium majus and their inhibitory effects on LPS-induced NO production in RAW264.7 cells
2011, Bioorganic and Medicinal Chemistry LettersComplementary and Alternative Medicine
2010, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and PrintChelidonium majus is not hepatotoxic in Wistar rats, in a 4 weeks feeding experiment
2009, Journal of EthnopharmacologyIrritable bowel syndrome: The complementary approaches considered
1995, Complementary Therapies in Medicine